Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

Simulations Plus Inc.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Compass Therapeutics (CMPX), Grace Therapeutics (GRC...

Analysts Offer Insights on Healthcare Companies: Compass Therapeutics (CMPX), Grace Therapeutics (GRCE) and Simulations Plus (SLP)

An update from LSL Property Services ( ($GB:LSL) ) is now available. LSL Property Services has continued its share buyback programme by repurchasin...

LSL Property Services Continues Share Buyback, Increases Treasury Holdings

Jefferies analyst Glynis Johnson maintained a Buy rating on LSL Property Services yesterday and set a price target of p361.00. Johnson covers the C...

LSL Property Services (LSL) Gets a Buy from Jefferies

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Simulations Plus (SLP) and Stryker (SYK) with bullis...

Analysts’ Top Healthcare Picks: Simulations Plus (SLP), Stryker (SYK)

Simulations Plus ( ($SLP) ) just unveiled an update. On April 9, 2026, Simulations Plus reported second‑quarter fiscal 2026 results for the period ...

Simulations Plus Reports Q2 2026 Results, Trims EPS Outlook

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alkermes (ALKS), ProQR (PRQR) and Simulations Plus...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS), ProQR (PRQR) and Simulations Plus (SLP)

LSL Property Services ( ($GB:LSL) ) has provided an announcement. LSL Property Services has continued its previously announced share buyback progra...

LSL Property Services Buys Back 30,000 Shares, Updates Voting Rights

An announcement from LSL Property Services ( ($GB:LSL) ) is now available. LSL Property Services plc has scheduled its 2026 Annual General Meeting ...

LSL Property Services Sets Date and Releases Documents for 2026 AGM

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Simulations Plus (SLP) and Mediwound (MDWD) with bul...

Analysts Offer Insights on Healthcare Companies: Simulations Plus (SLP) and Mediwound (MDWD)

Sylvania Platinum ( ($GB:SLP) ) has issued an announcement. Sylvania Platinum Limited has repurchased 145,000 ordinary shares on the market at an a...

Sylvania Platinum Bolsters Treasury Stock with Share Buyback

Sylvania Platinum ( ($GB:SLP) ) has issued an update. Sylvania Platinum Limited has repurchased 50,000 of its own ordinary shares on 30 March 2026 ...

Sylvania Platinum Buys Back 50,000 Shares for Treasury

The latest announcement is out from Sylvania Platinum ( ($GB:SLP) ). Sylvania Platinum, a South Africa-focused producer of platinum group metals an...

Sylvania Platinum Buys Back Shares, Trims Voting Float

LSL Property Services ( ($GB:LSL) ) has issued an announcement. LSL Property Services has published its Annual Report and Accounts for 2025, includ...

Market Cap	$347.60M	P/E Ratio	14.14
52W High	$36.45	52W Low	$11.09
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	-93.0%	52W Position	13.7%
Overall Score	61	Value Score	60
Quality Score	57	Technical Score	66

EPS Current Est	$1.03	EPS Next Est	$1.07
EPS Growth Est	+3.9%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	SLP	$14.56	+1.96%	203.58K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	SLP	$14.56	+2.0%	203.58K
3
4
5
6

SLP

SLP

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Simulations Plus Inc. Data in Excel

Get Simulations Plus Inc. Data in Excel